IBM has engineered a chemical that it says can block viruses like Zika, Ebola, dengue, influenza and herpes. (1)

ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, May 19, 2016 /EINPresswire.com/ --

“Infected with the herpes simplex virus (HSV-1 or HSV-2)? The CBCD recommends taking Gene-Eden-VIR or Novirin against the latent virus.” – Greg Bennett, CBCD

IBM has engineered a new macromolecule that attacks a number of viruses, including the herpes simplex virus (HSV) in at least three different ways, and all simultaneously. “First, it uses electrostatic bonds to attract a virus, locking on to it to prevent it from infecting other cells. It then neutralises the acidity levels inside virus cells, making it harder for them to replicate. Finally, it releases a type of sugar known as mannose that binds to healthy immune cells, preventing viruses from being able to infect them.” (1) The new macromolecule was created by the IBM Research and Singapore's Institute of Bioengineering, Nanotechnology (IBN). This is significant since herpes virus strains (usually HSV-1 and HSV-2) cause fever blisters, cold sores, and genital sores. Herpes is also one of the most common viruses. “The researchers surveyed a variety of representative viruses from various categories, including Ebola, dengue, Marburg, influenza, Chikungunya, Enterovirus 71 and herpes simplex. In early testing, scientists have seen no resistance to the latest macromolecule.” (1)

Click to learn more about herpes symptoms.

The Center for the Biology of Chronic Disease (CBCD) is encouraged by this new research. However, individuals should understand that any treatment based on this new research could take years to gain FDA approval and make it onto the market. Until that time, the Center for the Biology of Chronic Disease (CBCD) recommends that individuals infected with the latent herpes virus (HSV-1 or HSV-2) take Gene-Eden-VIR or Novirin. The formula of these natural, antiviral products was shown to reduce symptoms associated with herpes infections in two separate post-marketing clinical studies that followed FDA guidelines. In addition, the formula was designed to target the latent herpes virus.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD. The studies showed that the formula is effective against the herpes simplex virus, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HSV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (2) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses.

To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

Note: The formula of Novirin is the same as the formula of Gene-Eden-VIR. The difference between the two is that Novirin contains higher quality, and more expensive, ingredients.

“’Viral diseases continue to be one of the leading causes of morbidity and mortality,' said Dr Yi Yan Yang, Institute of Bioengineering and Nanotechnology, Singapore. 'We have created an anti-viral macromolecule that can tackle wily viruses by blocking the virus from infecting the cells, regardless of mutations.'It is not toxic to healthy cells and is safe for use. This promising research advance represents years of hard work and collaboration with a global community of researchers.'” (1)

What current treatments are available for herpes infections?

“Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (2) There are also the natural supplements Novirin and Gene-Eden-VIR, which have a formula that was designed to help the immune system target the herpes virus when it is in a latent form.

“We recommend that individuals who are infected with a latent herpes virus, take Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us Twitter here: @HananPolansky

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Mail Online
Ellie Dailymail.com - http://www.dailymail.co.uk/sciencetech/article-3587987/IBM-s-magic-bullet-destroy-Zika-Ebola-herpes-Firm-enlists-Watson-supercomputer-combat-killer-viruses.html

(2) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.VCvd5GeSz90

Greg Bennett
CBCD
585-250-9999
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.